New Review: The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma

Very excited to announce a new review from our PhD student Tom Johnson, in collaboration with Glen Reid’s laboratory, has been accepted and published in Frontiers in Cell and Developmental Biology. Its an excellent, comprehensive review of of the oncoprotein YB-1 in Lung Cancer and Mesothelioma. The review article is Open Access and free for […]

Read More New Review: The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma

New Co-Author paper out now in SciTransMed: Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

Very exciting day to see this amazing work by the lab of Prof.Neil Watkins published in the prestigious Science Translational Medicine Journal. A huge amount of work for a lot of very talented people over many many years went into this study, and hopefully it will result in significant improvements for the treatment of lung […]

Read More New Co-Author paper out now in SciTransMed: Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

New Co-author Publication: Hic1 maintains chromosomal stability independent of p53

Great news, we have a new co-author publication out in the journal Oncogene! The work was lead by Professor Neil Watkins, and is titled “The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53”. You can access the full article here [Link] ABSTRACT: Hypermethylated-in-Cancer 1 (Hic1) is a tumor suppressor gene frequently inactivated by epigenetic […]

Read More New Co-author Publication: Hic1 maintains chromosomal stability independent of p53